GlassScriptPhysician profile
Bhavik P Soni
NPI 1790892339
$1,506.20
in general payments reported to CMS, 2019-2025
19 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.98 · 2021: $73.27 · 2022: $41.54 · 2023: $283 · 2024: $653 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $242.55 | 2023-2025 | Adbry, Anzupgo |
| Abbvie INC. | $220.06 | 2022-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $198.59 | 2021-2025 | Libtayo, Dupixent |
| Janssen Biotech, INC. | $130.28 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $107.71 | 2024-2025 | Otezla, Otezla |
| Incyte Corporation | $99.93 | 2023-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $86.70 | 2024-2025 | |
| Genzyme Corporation | $75.61 | 2023-2025 | |
| Pfizer INC. | $73.30 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $51.68 | 2024-2025 | |
| Almirall LLC | $41.08 | 2024-2025 | Seysara, Klisyri |
| E.R. Squibb & Sons, L.L.C. | $33.53 | 2024-2025 | Sotyktu |
| Allergan, INC. | $26.10 | 2021 | |
| Organogenesis INC. | $22.42 | 2023 | Puraply |
| Lilly USA, LLC | $21.40 | 2025 | Ebglyss |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $21.26 | 2024 | Ayvakit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.26 | 2022 | |
| Dermira, INC. | $16.98 | 2020 | |
| Galderma Laboratories, L.P. | $16.76 | 2025 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavik Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.